Syntegon reports significant growth for the first half of 2025: sales rose by 11 per cent year-on-year to EUR 824 million, EBITDA increased by 41 per cent to EUR 127 million and the margin improved to 15.5 per cent.
According to Syntegon, it attributes this development to the growth strategy it has been pursuing since 2024, a strong order intake and efficiency improvements in all areas.
„The first half of 2025 underlines the strength of our strategy, our consistent execution and our commitment to helping customers succeed as a strategic lifecycle partner. With strong order intake and sales growth, improved margins in all business areas and continued efficiency gains in operations, Syntegon is on track for another record year.“
Torsten Türling, CEO of Syntegon
Pharma drives growth, Food improves profitability
In the pharma segment, the company benefited from continued momentum in the biologics business and regulatory requirements, which led to high order intake for aseptic fill & finish solutions with isolators. According to Syntegon, the new SVX product line and efficiency gains had a particularly positive impact on the margin in the food business.
Profitability increased across the Group. In addition to the volume effect in high-margin projects, Syntegon cites disciplined project implementation and synergies realised faster than expected from the Telstar takeover as the driver of the EBITDA margin of 15.5 per cent. CFO Eros Carletti said: „Our value creation programme and disciplined implementation are leading to higher margins and a sustainably strong cash flow.“
New RTU line „SynTiso“ presented
With the Pharma Day event in May 2025 Syntegon presented the gloveless, highly autonomous RTU line solution SynTiso for filling liquid pharmaceuticals. According to the company, SynTiso is Annex 1-compliant, was developed with two customers, offers high flexibility in dosing formats and is scheduled to be delivered for the first time from 2026.
Looking ahead and risk assessment
Syntegon believes that the potential impact of global trade developments - including new US tariffs - will only be minimal in 2025. The company points to countermeasures, a balanced supply chain and customer partnerships. Based on the order backlog, Syntegon anticipates further margin improvements in the second half of the year.
Source: Syntegon
